FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067024 [Registered on: 08/05/2024] Trial Registered Prospectively
Last Modified On: 07/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Mustakadi Yoga and Arjuna Churna in the management of Medodushti (Dyslipidaemia)  
Scientific Title of Study   Randomized comparative study to evaluate the efficacy of Mustakadi Yoga and Arjuna Churna in management of Medodushti Dyslipidemia 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Durgesh Kumar 
Designation  MD scholar  
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh 
Address  Room no 108 Department of Kayachikitsa Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh South West Delhi

South West
DELHI
110073
India 
Phone  9650690308  
Fax    
Email  jangradurgesh007@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Atal Bihari Trivedi 
Designation  Associate Professor  
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan Najafgarh  
Address  PG Department of Kayachikitsa, Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar South West DELHI

South West
DELHI
110073
India 
Phone  9958046550  
Fax    
Email  abdratal8@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Atal Bihari Trivedi 
Designation  Associate Professor  
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan Najafgarh  
Address  PG Department of Kayachikitsa, Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar South West DELHI


DELHI
110073
India 
Phone  9958046550  
Fax    
Email  abdratal8@gmail.com  
 
Source of Monetary or Material Support  
Chaudhary Brahm Prakash Ayurved Charak Sansthan khera dabar Najafgarh south west new delhi india 110073 
 
Primary Sponsor  
Name  Chaudhary Brahm Prakash Ayurved Charak Sansthan  
Address  Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh south west New Delhi india 110073 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Durgesh Kumar  Chaudhary Brahm Prakash Ayurved Charak Sansthan   Room no 108 Department of Kayachikitsa Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh South West Delhi 110073
South West
DELHI 
9650690308

jangradurgesh007@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Chaudhary Brahm Prakash Ayurved Charak Sansthan   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E782||Mixed hyperlipidemia. Ayurveda Condition: MEDOVAHASROTODUSHTIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Arjuna Churna , Reference: Bhavaprakash Nighnatu, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 75 Days, anupAna/sahapAna: Yes(details: Lukewarm water ), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Mustakadi Yoga , Reference: Charak sutra sthana, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 75 Days, anupAna/sahapAna: Yes(details: Luke warm water ), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1 Diagnosed and confirmed cases of Dyslipidemia based on investigation
2 Patients with total cholesterol above 200mg/dl
3 Patients with triglycerides above 150mg/dl or HDL below 40mg/dl, or LDL 100mg/dl or VLDL above 30mg/dl
4 Patient with any one or more Lakshana of Medodushti
5 Patient between the age group of 20-60 years of either sex who will fulfil the criteria of diagnosis
6 Patient having controlled diabetes mellitus and hypertension
7 Patients willing and able to participate for 8 weeks duration
8 Patients who are ready to give consent with firm home address and contact number which is readily accessible during coarse of trial 
 
ExclusionCriteria 
Details  1 Patient not willing for the trial
2 Patients with total cholesterol above 240mg/dl or LDL cholesterol above 160mg/dl or HDL cholesterol above 60mg/dl
3 Patient with Hypertension (Blood pressure greater than 160/100 mm of Hg)
4 Patient having illness like Tuberculosis, Carcinoma, or major illness like renal or Liver disorders
5 Patient having past-history of Myocardial Infarction, Unstable angina, and congestive cardiac failure
6 Patient below 20 years and above 60 years of age
7 History of hypersensitivity to any trial drug or their ingredients
8 Pregnant females and lactating mothers 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction in the haematological parameters of Dyslipidemia
Total Serum Cholesterol greater than or equal to 200mg/dl
Serum Triglycerides greater than or equal to 150mg/dl
Serum LDL Cholesterol greater than or equal to 100 mg/dl
Serum HDL Cholesterol less than 40mg/dl
Serum VLDL Cholesterol greater than 40mg/dl
 
75 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvements in the signs & symptoms of Medodushti- Dyslipidemia
1 Kshudra Shwasa-Breathlessness
2 Trishna-Polydipsia
3 Nidraadhikya-Excessive sleep
4 Kshudha Atimatra-Excessive hunger
5 Swedadhikya-Excessive sweating
6 Daurgandhya-Bad odour of body
7 Alpa Prana-Fatigue 
75 days 
 
Target Sample Size   Total Sample Size="52"
Sample Size from India="52" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   21/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Dyslipidemia is one of the major escalating public health challenge worldwide, arising as a result of combination of some genetic factors and more importantly certain environmental factors like sedentary lifestyle, increased urbanization, nutritional advancement accompanying economic development, substance abuse and other associated medical conditions. According to Acharya Sushruta, when there is excess deposition of Medadhatu in body it may produce excessive greasiness in the body which results in a very bad smell, enlargement of abdomen and flanks (pendular hanging), cough, breathlessness are some other symptoms. Samprapti of is Medadushti is when accumulated Meda dhatu blocks Strotasa’s other Dhatu’s are not properly nourished as a result Meda Dhatu further gets increased.x The person with Medo Roga will have Kshudra Shwas (breathlessness), Trisha (excessive thirst), Moha, Swapna (excessive sleep), Krathana (Sudden obstruction of breath), Sadana (looseness of the body) Kshuta (Excessive hunger) ,Sweda (excessive sweating), Daurgandhya(foul body smell), Alpa prana( Fatigue), Alpa Maithuna ( loss of libido)
The prevalence of Dyslipidemia varies around the world depending on the age and ethnicity of population studied. In general, its prevalence increases with age. Though it affects both the gender but studies have shown that males are more predisposed than females. The Indian council of medical research Sevillians project reported a prevalence of Dyslipidemia of 37.5% amongst adults aged between 15-64 years. the present study aims to evaluate the role of mustakadi yoga and arjuna churna  in the management of dyslipidemia. total number of patients is 52,26 in each group. in group A, mustakadi yoga will be administered at a dose of 3gm BD with luke warm water empty stomach in early morning and evening.  In group B, arjuna churna is adminstered at a dose of 3gm BD with luke warm water empty stomach in early morning and evening.
The design of study is a single centred ,open-labelled,Randomized,comparative,interventional study
 
Close